Marta Afonso

Has grant

Assistant Professor

Faculty of Pharmacy, University of Lisbon

Portugal

Research Interests

Explore related searches

Professors in Portugal Professors in Cancer Biology Cancer Biology professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marta Afonso is an Assistant Professor at the Faculty of Pharmacy, Universidade de Lisboa. Her research primarily focuses on metabolic dysfunction, liver disease, cancer immunotherapy, and the role of adipokines in gastrointestinal cancers. Recent publications include studies on the interplay between metabolism and necroptosis, along with the development of multifunctional nanovaccines for cancer treatment.

Recent Grants

Grant: Close

Unveil the role of Limosilactobacillus D-lactate to treat NAFLD

Open Date: 2022-01-01

Close Date: 2023-01-01

Grant: Close

Translating RIPK3 signalling into application in metabolic liver disease (PTDC/MED-FAR/3492/2021)

Open Date: 2022-01-01

Close Date: 2024-01-01

Grant: Close

R.I.P._HCC - O papel da RIPK3 na progressão para carcinoma hepatocelular

Open Date: 2020-01-01

Close Date: 2021-01-01

Grant: Close

“MicroRNAs como biomarcadores diagnósticos de la evolución del daño hepático y papel en la enfermedad en pacientes ancianos”

Open Date: 2019-01-01

Close Date: 2019-01-01

Grant: Close

Targeting Cancer stem cells with artimisin-vinyl sulfone hybrids: towards target identification

Open Date: 2019-01-01

Close Date: 2020-01-01

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Carina Prip-Buus

CNRS Délégation Paris B

FRANCE

Marta Afonso

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review

miR‐21‐5p promotes NASH‐related hepatocarcinogenesis

Modulation of rectal cancer stemness, patient outcome and therapy response by adipokines

Microfluidic Detection of Adenylate Kinase as a Cell Damage Biomarker

Monocarbonyl Analogs of Curcumin with Potential to Treat Colorectal Cancer

Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors

Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

The necroptosis-inducing pseudokinase mixed lineage kinase domain-like regulates the adipogenic differentiation of pre-adipocytes

The role of RIPK3 in liver mitochondria bioenergetics and function

Disclosing the antitumour potential of the marine bromoditerpene sphaerococcenol A on distinct cancer cellular models

Towards personalized antibody cancer therapy: development of a microfluidic cell culture device for antibody selection

Collaborators (22)

Carina Prip-Buus

Cecilia Maria Pereira Rodrigues

Rita C. Guedes

Aimo Kannt

Fiona Oakley

Colm O'Rourke

José Teixeira

Rui Pedrosa

Marcia Ines Goettert

Ann Driessen

Helena F Florindo

Antonio Mazzocca

Rui Castro

Liana C. Silva

Cristina Alonso

Romina Guedes

Helena Gaspar

Jérémie Gautheron

Joao Pedro Conde

Matej Oresic

Ana S. Viana

Ann Daly

Make your next move.